Anaphylaxis in children and adolescents: The European Anaphylaxis Registry

• Published in: Journal of allergy and clinical immunology Vol. 137; no. 4; pp. 1128 - 1137.e1
• Main Authors: Grabenhenrich, Linus B., MD, MPH, Dölle, Sabine, PhD, Moneret-Vautrin, Anne, MD, Köhli, Alice, MD, Lange, Lars, MD, Spindler, Thomas, MD, Ruëff, Franziska, MD, Nemat, Katja, MD, Maris, Ioana, MD, Roumpedaki, Eirini, MD, Scherer, Kathrin, MD, Ott, Hagen, MD, Reese, Thomas, MD, Mustakov, Tihomir, MD, Lang, Roland, PhD, Fernandez-Rivas, Montserrat, MD, Kowalski, Marek L., MD, PhD, Bilò, Maria B., MD, Hourihane, Jonathan O'B., MD, Papadopoulos, Nikolaos G., MD, Beyer, Kirsten, MD, Muraro, Antonella, MD, Worm, Margitta, MD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2016; Elsevier Limited
• Subjects: Adolescent; Age; Allergies; Allergy and Immunology; Anacardium; Anaphylaxis; Anaphylaxis - diagnosis; Anaphylaxis - epidemiology; Anaphylaxis - etiology; Anaphylaxis - therapy; Arachis hypogaea; arthropod venoms; Child; Child, Preschool; Corylus; Counseling; Data entry; drug hypersensitivity; Emergency Treatment; epinephrine; Europe - epidemiology; Family medical history; Female; food hypersensitivity; Health Care Surveys; Health Surveys; Humans; Immunotherapy; Infant; Infant, Newborn; Male; Pediatrics; Questionnaires; Registries; Retrospective Studies; Teenagers; Europe; arthropod venoms; food hypersensitivity; epinephrine; Anaphylaxis; registries; drug hypersensitivity
• ISSN: 0091-6749; 1097-6825
• DOI: 10.1016/j.jaci.2015.11.015

Background Anaphylaxis in children and adolescents is a potentially life-threatening condition. Its heterogeneous clinical presentation and sudden occurrence in virtually any setting without warning have impeded a comprehensive description. Objective We sought to characterize severe allergic reactions in terms of elicitors, symptoms, emergency treatment, and long-term management in European children and adolescents. Methods The European Anaphylaxis Registry recorded details of anaphylaxis after referral for in-depth diagnosis and counseling to 1 of 90 tertiary allergy centers in 10 European countries, aiming to oversample the most severe reactions. Data were retrieved from medical records by using a multilanguage online form. Results Between July 2007 and March 2015, anaphylaxis was identified in 1970 patients younger than 18 years. Most incidents occurred in private homes (46%) and outdoors (19%). One third of the patients had experienced anaphylaxis previously. Food items were the most frequent trigger (66%), followed by insect venom (19%). Cow's milk and hen's egg were prevalent elicitors in the first 2 years, hazelnut and cashew in preschool-aged children, and peanut at all ages. There was a continuous shift from food- to insect venom– and drug-induced anaphylaxis up to age 10 years, and there were few changes thereafter. Vomiting and cough were prevalent symptoms in the first decade of life, and subjective symptoms (nausea, throat tightness, and dizziness) were prevalent later in life. Thirty percent of cases were lay treated, of which 10% were treated with an epinephrine autoinjector. The fraction of intramuscular epinephrine in professional emergency treatment increased from 12% in 2011 to 25% in 2014. Twenty-six (1.3%) patients were either admitted to the intensive care unit or had grade IV/fatal reactions. Conclusions The European Anaphylaxis Registry confirmed food as the major elicitor of anaphylaxis in children, specifically hen's egg, cow's milk, and nuts. Reactions to insect venom were seen more in young adulthood. Intensive care unit admissions and grade IV/fatal reactions were rare. The registry will serve as a systematic foundation for a continuous description of this multiform condition.